Pharmaceutical company “Biofarma” plans to start operation of the plant fractionator blood plasma in July 2018, said the President of the company “Biopharma” Konstantin Efimenko on his page on the social network Facebook.

“In December we will receive the separators of the German company GEA Westfalia in February – bioreactor Italian company Olsen, chromatography systems, and ultrafiltration installation from the world’s leading companies such as General Electric, the bottling line, the company Marchesini and in July opened a modern factory-fractionator”, – he said.

The design capacity of fractionator, whose construction was invested $35 million, will amount to 500 tonnes of blood plasma.

“We have a clear purpose and plan to become a world leader in supply to the market, we have the ambition to enter the seven of the world’s biggest manufacturers of blood plasma”, – said K. Efimenko.

OOO “Biofarm” is among the ten largest Ukrainian manufacturers of medicines. Produces more than 20 immunobiological preparations from donor blood, drugs obtained by recombinant DNA technology and probiotics.

In 2015, the company invested $3.5 million in reconstruction of the Sumy regional blood center (SISC), which currently provides a solid billet of 98.2% of donor blood and its components in the field.